Building Bridges

Jul 16, 2022
Latest in Clinical News
Cash
Vexev raises $6M for vascular imaging platform
August 6, 2026
Representative amyloid PET images acquired with flutemetamol, florbetaben, and florbetapir across a range of Centiloid values.
Amyloid PET scores vary with reference-region choice, Spanish study finds
August 5, 2026
Mars Extremity Imaging System
MARS Bioimaging installs first portable photon-counting CT system
August 5, 2026
Fatigue is one of the most common and debilitating symptoms of Long COVID.
Multi-organ MRI shows no added benefit in major UK Long COVID trial
August 4, 2026
Related Stories
2021 03 11 21 54 5662 Computer Ai Artificial Illustration 400
Conference
ECR: AI could avoid further follow-up for lung nodules
2022 07 16 01 15 4638 Patient Woman X Ray Shielding 400
Conference
ECR: Should patient shielding stay or should it go?
2022 07 16 00 10 1512 2022 07 16 Ecr 2022 Radbruch Alexander 400
Conference
Video from ECR 2022: Alexander Radbruch on gadolinium retention
2016 11 16 11 11 54 211 2016 11 16 Kuhl Thumb
Conference
Video from ECR 2022: Christiane Kuhl on breast MRI and life on the farm
More in Clinical News
Vexev raises $6M for vascular imaging platform
By AuntMinnie.com staff writers
VxWave combines robotics, AI, and ultrasound to automate vascular ultrasound acquisition, with dialysis vascular access as its initial application.
August 6, 2026
Cash
Amyloid PET scores vary with reference-region choice, Spanish study finds
By Claudia Tschabuschnig
A Spanish study found that the brain region used as a reference can substantially alter Centiloid scores, while whole-cerebellum normalization produced the most consistent results.
August 5, 2026
Representative amyloid PET images acquired with flutemetamol, florbetaben, and florbetapir across a range of Centiloid values.
MARS Bioimaging installs first portable photon-counting CT system
By AuntMinnie.com staff writers
The installation is the first following U.S. Food and Drug Administration (FDA) 510(k) clearance of the system in March.
August 5, 2026
Mars Extremity Imaging System
Multi-organ MRI shows no added benefit in major UK Long COVID trial
By Claudia Tschabuschnig
A major UK trial found no benefit from routinely adding multi-organ MRI to specialist Long COVID care. Abnormalities were detected, but fatigue and quality of life did not improve.
August 4, 2026
Fatigue is one of the most common and debilitating symptoms of Long COVID.
GE HealthCare launches Logiq e compact ultrasound system family
By AuntMinnie.com staff writers
The Logiq e X and Logiq e S systems are designed for point-of-care use across a variety of clinical settings.
August 4, 2026
Logiq e X
Europe’s lung screening training gaps sharpen focus on implementation
By Claudia Tschabuschnig
A new SOLACE survey reveals wide variation in lung cancer screening training across Europe, underscoring the need for harmonized standards and coordinated care pathways.
August 3, 2026
Lung Cancer Stages 400
RevealDx secures distribution deal, $3.4M investment from 4DMedical
By AuntMinnie.com staff writers
Under the agreement, 4DMedical will distribute RevealAI-Lung in the U.S., Europe, Australia, and New Zealand.
August 3, 2026
Acquisitions
FDG-PET/CT sharpens surveillance after colorectal liver metastasis treatment
By Claudia Tschabuschnig
A Dutch study found that adding metabolic imaging to contrast-enhanced CT improved early detection of local tumor progression after liver ablation or resection, including disease missed by CT alone.
July 30, 2026
Three months after thermal ablation, contrast-enhanced CT (A, B) shows post-treatment changes without clear local progression, while FDG-PET/CECT (C–F) reveals focal uptake suspicious for recurrence.
Median Technologies signs Canon Medical partnership for eyonis LCS
By AuntMinnie.com staff writers
Canon's subsidiary Olea Medical will leverage its CT imaging platform to support distribution of Median's software.
July 30, 2026
Business Handshake Intelligence 400 (1)
Scottish team designs 10-year sustainability model for preclinical imaging
By Claudia Tschabuschnig
A Scottish team has designed a theoretical 10-year strategy for keeping a multimodal preclinical imaging facility financially viable, operationally resilient, environmentally responsible, and accessible to researchers.
July 29, 2026
Pexels Thirdman 8940356 (1)
ESMI review maps cancer biology ahead of TOPIM 2026
By Claudia Tschabuschnig
Ahead of TOPIM 2026, a new Nature Reviews Cancer article explores how molecular imaging can reveal the biological processes driving tumor growth, resistance, and immune evasion.
July 28, 2026
Overview of the hallmarks of cancer and the imaging modalitites that are being used to assess them.
ITM launches new oncology therapeutics division
By AuntMinnie.com staff writers
Lumara Bio will focus resources toward commercial readiness for ITM's lead drug candidate, lutetium-177 (Lu-177) edotreotide (ITM-11).
July 27, 2026
Lumara
Page 1 of 1328
Next Page